Research Article

Investigation of Anti-CA II Antibodies in The Sera of Helicobacter Pylori Infected Patients

Volume: 46 Number: 1 March 25, 2025
EN

Investigation of Anti-CA II Antibodies in The Sera of Helicobacter Pylori Infected Patients

Abstract

It has been postulated that there may be a correlation between gastric infection caused by Helicobacter pylori (H. Pylori) and autoimmune pancreatitis (AIP). An increase in carbonic anhydrase II (CA II) autoantibodies was found in the sera of patients with AIP and it was suggested that measurement of these autoantibodies could be used in the diagnosis of AIP. In this study, the levels of CA II autoantibodies have been determined in the sera of the patients with H. pylori-infected gastritis and gastric ulcer. Anti-CA II antibody levels in the sera of these individuals were measured by ELISA method. There were significant differences between the control group and the H. pylori-infected gastric ulcer group and the gastritis group. When the H. pylori-infected and non-infected gastric ulcer and gastritis groups were compared, it became apparent that there were notable differences. The results indicated that the CA II antibodies in the sera of the H. pylori-infected patients were present at a rate of 8.3%. This led to the conclusion that CA II antibodies may not be a reliable marker for H. pylori infection. However, the investigation did demonstrate a clear increase in the levels of CA II antibodies for H. pylori-infected patients.

Keywords

References

  1. [1] Supuran C. T., Novel carbonic anhydrase inhibitors for the treatment of Helicobacter pylori infection, Expert Opinion on Investigational Drugs, 33(5) (2024) 523–532.
  2. [2] Bayram E., Senturk M., Kufrevioglu O. I., Supuran C. T., In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II, Bioorganic & Medicinal Chemistry, 16(20) (2008) 9101–9105.
  3. [3] Alver A., Menteşe A., Karahan S. C., Erem C., Keha E. E., Arikan M. K., Eminağaoğlu M. S., Deger O., Increased serum anti-carbonic anhydrase II antibodies in patients with Graves' disease, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 115(5) (2007) 287–291.
  4. [4] Nishimori I., Onishi S., Takeuchi H., Supuran C. T., The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets, Current Pharmaceutical Design, 14(7) (2008) 622–630.
  5. [5] Janeway C.A., Travers P., Walport M., Immunobiology: The Immune System in Health and Disease, 5th ed. New York: Garland Science; 2001.
  6. [6] Nista E. C., De Lucia S. S., Manilla V., Schepis T., Pellegrino A., Ojetti V., Pignataro G., Zileri Dal Verme L., Franceschi F., Gasbarrini A., Candelli M., Autoimmune Pancreatitis: From Pathogenesis to Treatment, International Journal of Molecular Sciences, 23(20) (2022) 12667.
  7. [7] Inagaki Y., Jinno-Yoshida Y., Hamasaki Y., Ueki H., A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome, Journal of Dermatological Science, 2(3) (1991) 147–154.
  8. [8] Yokode M., Shiokawa M., Kodama Y., Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?, Diagnostics (Basel, Switzerland), 11(5) (2021) 770.

Details

Primary Language

English

Subjects

Microbiology (Other) , Medical Biochemistry - Proteins, Peptides and Proteomics

Journal Section

Research Article

Publication Date

March 25, 2025

Submission Date

September 17, 2024

Acceptance Date

February 12, 2025

Published in Issue

Year 2025 Volume: 46 Number: 1

APA
Yiğit Alaşalvar, S., Şahin, E., & Keha, E. E. (2025). Investigation of Anti-CA II Antibodies in The Sera of Helicobacter Pylori Infected Patients. Cumhuriyet Science Journal, 46(1), 22-26. https://doi.org/10.17776/csj.1549477

As of 2026, Cumhuriyet Science Journal will be published in six issues per year, released in February, April, June, August, October, and December